Squalene is the main unsaponifiable component of virgin olive oil, the main source of dietary fat in Mediterranean diet, traditionally associated with a less frequency of cardiovascular diseases. In this study, two experimental approaches were used. In the first, New Zealand rabbits fed for 4 weeks with a chow diet enriched in 1% sunflower oil for the control group, and in 1% of sunflower oil and 0.5% squalene for the squalene group. In the second, APOE KO mice received either Western diet or Western diet enriched in 0.5% squalene for 11 weeks. In both studies, liver samples were obtained and analyzed for their squalene content by gas chromatography-mass spectrometry. Hepatic distribution of squalene was also characterized in isolated subcellular organelles. Our results show that dietary squalene accumulates in the liver and a differential distribution according to studied model. In this regard, rabbits accumulated in cytoplasm within small size vesicles, whose size was not big enough to be considered lipid droplets, rough endoplasmic reticulum, and nuclear and plasma membranes. On the contrary, mice accumulated in large lipid droplets, and smooth reticulum fractions in addition to nuclear and plasma membranes. These results show that the squalene cellular localization may change according to experimental setting and be a starting point to characterize the mechanisms involved in the protective action of dietary squalene in several pathologies.
Introduction
Nonalcoholic fatty liver disease (NAFLD) is now viewed as a considerable health issue since it affects about 25% of the US population, and up to 30% of these patients will develop more severe diseases such as nonalcoholic steatohepatitis (NASH), cirrhosis, and in some cases, hepatocellular carcinoma [14] . The liver, as an organ with a major role in metabolizing glucose, fatty acids, and cholesterol, seems particularly sensitive to the increased incidence of human obesity in the modern society and is becoming a lipid-accumulating tissue as well, and as consequence, promoting insulin resistance in human peripheral tissues [12] . NAFLD does not show symptoms so, when detected in a regular analytical, it is complicated to reverse the damage for the advanced stages of the disease, and it is crucial to identify the first symptoms to provide early effective treatment for this ailment [4] .
Squalene is an isoprenoid lipid belonging to the terpene family with linear structure and six double bounds, firstly isolated from shark livers where it accumulates with no [19] . In addition, it is also present in amaranth and virgin olive oils [19] . Squalene is the precursor of sterol biosynthesis in all cell types and is located in the midplane of the lipid bilayer [9] . Moreover, it has been proposed that squalene could be a bioactive compound [17] able to act as antioxidant [5, 20, 30] , anti-inflammatory [6, 7, 23] , or as antineoplastic agent against skin, colon, and lung cancer cells as well as sarcoma [16, 18, 22, 24] . Not surprisingly, some authors have considered it as an effective therapeutic agent in treatment of age-associated disorders where free radicals are a major causative factor [1] .
Using APOE-KO mice as model of spontaneous atherosclerosis and fatty liver [3] , the administration of dietary squalene decreased atherosclerotic lesion, and in males, this lesion correlated with hepatic fat content, which suggested that squalene administration could be used as a safe alternative to correct hepatic steatosis and atherosclerosis, particularly in males [8] . Using high-throughput approaches, it was found that the normalization of the steatotic liver by squalene was associated with complex mechanisms involving mitochondria and endoplasmic reticulum [20, 21] . Recently, it has been shown in HepG2 cells that squalene behaves as a peroxisome proliferator-activated receptor-α agonist, decreasing cellular triacylglycerol and cholesterol concentrations, while fatty acid uptake was increased [10] . These facts, together with that the liver is the main squalene body storage [9, 27] , make this compound an attractive agent in the field of NAFLD. In adipose tissue, two pools of squalene were shown to exist, one in lipid droplets and other in microsomes [28] . To our knowledge, no study has addressed the subcellular distribution of squalene in the liver and mechanisms controlling those pools. The present endeavor has set up to characterize the subcellular distribution of squalene in two animal models.
Material and methods

Animals and diets
During 4 weeks, two groups of six male New Zealand rabbits were fed with a chow diet enriched with 1% of sunflower oil for the control group, and with 1% of sunflower oil and 0.5% of squalene for the squalene group. After this period, the rabbits were fasted for 18 h and liver was obtained for assays. The samples were stored at − 80°C.
The mice experiment used two groups of 17 male APOE-KO, which were fed a purified Western diet for the control group and a purified Western diet supplemented with 0.5% of squalene for the squalene group. After the 10-week diet intervention, and 4-h fast, the animals were killed by suffocation with CO 2 . The livers were removed, weighed, frozen in liquid nitrogen, and stored at − 80°C until analysis.
Preparation of cellular fractions
For the preparation of cellular fractions, we used 4 g of pooled livers of each experimental group and animal model and followed the protocol shown in Fig. 1 adapted from [11, 25] . In a Potter, the frozen liver was homogenized in cooled 40 ml of 0.25 M sucrose/5 mM Tris HCl, pH 7.4/ 1.0 mM MgCl 2 solution, with protease and phosphatase inhibitors (Sigma-Aldrich, Saint Louis, MO, USA), at concentrations according to manufacturer instructions. Homogenized tissue was filtered through sterile gauze and centrifuged at 280g for 5 min. The pellet was discarded, and the supernatant was centrifuged at 1500g for 10 min, resulting in the pellet, which contained nuclei and membranes, and a supernatant that was again centrifuged at 19,000g for 20 min. After this centrifugation, the pellet contained mitochondria, lysosomes, and peroxisomes, and the supernatant was centrifuged at 34,000g for 30 min. The latter centrifugation step resulted in a new pellet named light microsomes, and a supernatant that was centrifuged at 124,000g for 30 min. The resulting pellet was dubbed heavy microsomes. Both microsomal fractions were diluted until 5 ml with 0.25 M sucrose and 0.015 M CsCl. A discontinuous gradient was generated by adding 7 ml of 1.3 M sucrose and 0.015 M CsCl, added on top of the 5 ml microsomal-containing fraction. The gradient was centrifuged at 237,000g for 120 min, and the resulting pellet contained the rough ER (rER) [25] . The supernatant was diluted in an equal volume of 0.25 M sucrose, and centrifuged at 124,000g for 60 min. The pellet obtained contained the smooth ER (sER). Each obtained sample was immediately frozen in liquid nitrogen and stored at − 80°C until sample processing.
Extraction and solid-phase extraction (SPE)
In this process, all used chemicals were of CG-MS quality. We used a cellular fraction aliquot equivalent to 0.1 g of tissue, according to weight of samples and volumes used in each step. Samples was transferred to a centrifuge glass tube and homogenized in 1 ml of PBS, and 200 μl of 932 μM 5α-cholestane in dichloromethane as internal standard for determining the efficiency of the extraction. Samples were extracted with 1 mL of hexane and vortexed for 5 s. Then, tubes were centrifuged at 2200g for 10 min, and the organic phase was transferred to a clean tube. To improve the efficiency, this extraction process was repeated twice. The collected organic phases were combined and a further step of purification using SPE was included in order to eliminate other lipids and phospholipids and to improve chromatogram background. This is critical for samples with low squalene concentrations, so the obtained hexane extracts were passed through a SPE cartridge, EFS SiOH (Análisis Vínicos, Tomelloso, Spain; 200 mg/3 mL), previously equilibrated with 1.6 mL of hexane. Elution was obtained by adding 1.6 mL of hexane at a constant flow of 1.0-1.5 mL/min. Eluted samples were dried using a N 2 stream in a thermostatic bath at 55°C. Then, they were dissolved with 200 μL of 72 μM squalane solution in dichloromethane. To facilitate complete dissolution of tube residue, they were sonicated for 3 min. Samples were transferred to 150 μL vial insert into a 2-mL vial and were ready for chromatographic analysis.
Gas chromatography-mass spectrometry (GC-MS)
CG analyses were carried out in an Agilent 6890 CG with a 7683B Injector and a 5975B MS acquisition parameter unit (Agilent Technologies, Santa Clara, CA, USA), using a J&W122-5532 column (Agilent) with a nominal length of 30 m and a diameter of 0.25 mm and a helium flow of 1 mL/min. Oven temperature was set up to operate from 280 to 290°C in 15 min with a ramp from 5 to 13 min. Peak identification was done by comparison of the retention times of sample peaks with those of individual standards (squalane, squalene, and 5α-cholestane with retention times of 9.8, 11.3, and 12.2 min), and the ion mass patron of each compound, using the m/z of 69.1 for squalene, 113 for squalane, and 217.2 for 5α-cholestane. The used linear calibration curve to determine squalene concentration was comprised between 0 and 500 μM. Concentrations of internal standards were 932 and 72 μM for 5α-cholestane and squalane, respectively.
Histological analyses
A sample of liver from each animal was stored in neutral formaldehyde and embedded in paraffin wax. Sections (4 μm) were stained with hematoxylin and eosin and observed using a Nikon microscope. A slide scanner Zeiss AsioScan.Z1 (Zeiss, Oberkochen, Germany) was used to record all preparations. Hepatic fat content was evaluated by quantifying the extent of lipid droplets in each liver section with Adobe Photoshop 7.0 and expressed as percentage of total liver section [8] .
Hepatic lipid analyses
Hepatic lipids were extracted from approximately 10 mg of liver. The tissue was homogenized in 1 ml of PBS. The homogenate was twice extracted with 2 mL of chloroform/ methanol (2:1). The separated organic phases of each animal were combined and evaporated under N 2 stream. Extracts were dissolved in 100 μL of isopropanol to estimate cholesterol and triglyceride concentrations using commercial kits from ThermoFisher Scientific (Waltham, MA, USA) [15] .
Statistical analyses
Results are expressed as median and interquartile range. Comparisons were made using the Mann-Whitney U test. Correlations between variables were sought using the Spearman's correlation test. All calculations were performed using SPSS version 15.0 software (SPSS Inc., Chicago, IL, USA). Significance was set at P ≤ 0.05. fat expressed as percentage of surface which was close to 5%. No significant differences were observed by the administration of squalene. Likewise, no changes were found for hepatic triglyceride (Fig. 2c) and cholesterol (Fig. 2d) contents. However, a significant increase in squalene content in those rabbits supplemented with this compound as 0.5% in their diet was observed (Fig. 2e) .
Results
Histological analyses and chemical composition of the rabbit and mouse liver
In Fig. 2f , two representative micrographs of control and squalene-supplemented APOE-KO mice are shown. As reflected by the data in Fig. 2g , fat extension in the liver of these mice represented a higher amount (25%) when compared to rabbits (Fig. 2b) , with no significant difference between control and treated mice. In agreement with this, hepatic triglycerides (Fig. 2h) did not experience any significant change. Squalene administration increased significantly the hepatic cholesterol levels (Fig. 2i) and squalene content (Fig.   2j ). The amount of squalene observed in this model was twice the amount present in rabbits receiving the same food content.
Hepatic subcellular distribution of squalene in function of treatment
In Fig. 3 , the main organelles experiencing changes by the administration of squalene have been represented. A differential pattern was observed according to the model studied. In this regard, treated rabbits accumulated it in the cytosolic, nuclear and plasma membranes, and rough endoplasmic reticulum fractions (Fig. 3a) . Interestingly, mice, with a higher degree of basal steatosis as abovementioned, showed a preferential increase in lipid droplets, nuclear and plasma membranes, and smooth reticulum fractions (Fig. 3b) . are shown as median and interquartile ranges of n = 6 for each rabbit group, and n = 10 and n = 9 for mouse control and squalene groups. Statistical analysis was carried out by Mann-Whitney U test. *P < 0.05 and **P < 0.01
Rabbit
Associations among hepatic parameters
To gain insight into the meaning of observed changes, a correlation analysis was carried out among different parameters. As shown in Fig. 4a , c, squalene content was directly associated with hepatic cholesterol content in both studied models. Equally associated was found the content of triglycerides and fat assayed by the morphometric procedure in mice (Fig. 4b) .
Discussion
The present work has characterized in depth the distribution of squalene in subcellular fractions thanks to an optimization of its assay and using the combined analytical power of gas chromatography and mass spectrometry. Both animal models accumulated squalene in the liver being more sensitive the mouse model. Equally, there was a differential distribution in both models in terms of preferential distribution in endoplasmic reticulum and cytosolic compartments.
Our data using two animal models show clearly that exogenous administration of squalene in vivo increases the reservoir in the liver independently of studied model in agreement with classical studies [13] . Besides, the differences in accumulation may be due to experimental settings such as dietary fat percentage in used diets or the models. When we administered squalene in low-fat diet to APOE-KO mice, we observed low levels of hepatic squalene [8] . Based on the latter data, it seems plausible that dietary fat content is crucial to facilitate intestinal squalene absorption. Nevertheless, it cannot be rejected the potential role of hepatic adaptation to engorge more squalene when large lipid droplets are present, such is the case of a more severe steatotic liver developed by APOE-KO mice fed Western diet.
The present experiments were designed to reduce the dose of (1 g/kg) squalene previously used [8] in an attempt to reach the moderate dietary intakes reported using virgin olive [19] . The 0.5 mg/kg dose was selected because the 0.25 mg/kg dose was not particularly effective in many plasma parameters [5] . However, squalene administration failed to decrease hepatic triglyceride content at the 0.5 mg/kg dose, suggesting that squalene dose seems to be critical regarding this effect.
The distribution of squalene among cytosolic and reticulum in both models is confirmatory for the liver of results observed by Tilvis et al. [28] in adipocytes. However, a profound analytical development has unveiled a new source (nuclei and plasma membranes) with important consequences regarding transcriptional changes induced by squalene action [20, 21] . This nuclear location could also be the responsible for the protection of DNA damage reported in MCF10A human mammary epithelial cells [30] . Equally remarkable is the differential accumulation in potential small vesicles isolated from cytosol for rabbits or the large lipid droplet isolated at lower centrifugal force for mice. This fact may be related to the higher amount of squalene in the latter model, and it would have required an expansion of lipid droplets in terms of phospholipids and proteins [26] . In yeast, it has been proposed that squalene is lipotoxic if not adequately sequestered in lipid droplets [29] . Surprisingly, it seems that the liver can handle it with ease due to the low toxicity observed in sharks, which accumulate [19] . New unsuspected information gained through meticulous analyses of reticulum adds a complexity that could be speciesspecific. Not much is known for proteins carrying squalene in the aqueous cell environment. In this regard, supernatant protein factor has been proposed as a candidate [2] , but how its mechanism of action is not well known. Selective accumulation of squalene in specific domains of reticulum and the positive association with cholesterol content observed in our models (Fig. 4) c Relationship between squalene and cholesterol contents in mice epoxidase, the enzyme using squalene as substrate. Besides, considering the ability of this compound to be intercalated into the layer of membranes [9] is may just merely represent the existence of these specific domains able to accrue it.
In conclusion, the present results provide a suggestive framework to further advance in the knowledge of protective action of squalene in the liver by opening unsuspected locations of squalene in nuclei and the cellular dynamics of squalene between vesicles/lipid droplets and endoplasmic reticulum. These facts warrant further research to unveil them.
